Breast Cancer Type 2 Susceptibility Protein (BRCA2) Antibody
52€ (10 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Name
Breast Cancer Type 2 Susceptibility Protein (BRCA2) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx013516
Tested Applications
ELISA, IHC
Description
Rabbit polyclonal antibody against BRCA2 protein. Immunogen region is N-terminal.
Documentos del producto
Instrucciones
Data sheet
Especificaciones del producto
| Category | Primary Antibodies |
| Immunogen Target | Target: Breast Cancer Type 2 Susceptibility Protein (BRCA2) Immunogen: The antiserum was produced against synthesized peptide derived from N-terminal of human BRCA2. |
| Host | Rabbit |
| Reactivity | Human, Rat |
| Assay Type | Concentration: 1 mg/ml |
| Recommended Dilution | IHC: 1/50 - 1/100, ELISA: 1/20000. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen. |
| Size 1 | 10 µg |
| Size 2 | 20 µg |
| Size 3 | 100 µg |
| Size 4 | 200 µg |
| Size 5 | 300 µg |
| Form | Liquid |
| Tested Applications | ELISA, IHC |
| Buffer | PBS (without Mg<sup>2+</sup> and Ca<sup>2+</sup>), pH 7.4, 150 mM NaCl, 0.02% sodium azide, 50% glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P51587 |
| Alias | BRCC2,BROVCA2,FACD, FAD,FAD1,FANCD,FANCD1,GLM3,PNCA2,XRCC11,Fanconi anemia group D1 protein |
| Background | Antibody anti-BRCA2 |
| Status | RUO |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
Background
BRCA2 is a tumor suppressor protein that plays a pivotal role in maintaining genomic stability by facilitating the repair of DNA double-strand breaks through homologous recombination. It interacts with RAD51, a recombinase protein, to mediate the precise alignment and strand exchange during DNA repair. Structurally, BRCA2 contains eight BRC repeats that directly bind RAD51 and a DNA-binding domain that targets damaged DNA regions. Mutations in the BRCA2 gene are strongly associated with an increased risk of hereditary breast, ovarian, and other cancers, such as pancreatic and prostate cancer. These mutations often lead to truncated or dysfunctional proteins, resulting in impaired DNA repair and genomic instability, which drives tumorigenesis. Beyond its role in DNA repair, BRCA2 is also implicated in cell cycle regulation and replication fork protection. BRCA2 deficiency is therapeutically targeted using PARP inhibitors, exploiting synthetic lethality to selectively kill BRCA2-mutant cancer cells while sparing normal cells. This approach has revolutionized treatment options for BRCA2-associated cancers, emphasizing its clinical significance.
Productos relacionados
BRCA2 (Phospho-Ser3291) Antibody
Rabbit polyclonal antibody against BRCA2 protein. Immunogen region is C-terminal. Specificity is as follows for the reac…
Ver producto Breast Cancer Type 2 Susceptibility Protein (BRCA2) Antibody
Rabbit polyclonal antibody against BRCA2 protein. Immunogen region is N-terminal.…
Ver producto
Human Breast Cancer Susceptibility Protein 2 (BRCA2) Protein
Human Breast Cancer Susceptibility Protein 2 (BRCA2) is a recombinant Human protein expressed in E. coli.…
Ver producto